These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2448207)

  • 21. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new familial variant of antithrombin III: 'antithrombin III Paris'.
    Wolf M; Boyer C; Lavergne JM; Larrieu MJ
    Br J Haematol; 1982 Jun; 51(2):285-95. PubMed ID: 7082587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.
    Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML
    Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
    Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
    Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive thrombus formation with heparin resistance during extracorporeal circulation. A new presentation of familial antithrombin III deficiency.
    Nielsen LE; Bell WR; Borkon AM; Neill CA
    Arch Intern Med; 1987 Jan; 147(1):149-52. PubMed ID: 3800516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.
    Girolami A; Fabris F; Cappellato G; Sainati L; Boeri G
    Blut; 1983 Aug; 47(2):93-103. PubMed ID: 6871478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of familial antithrombin III variant complicated by recurrent pulmonary infarction].
    Nakano Y; Sato A; Okano A; Chida K; Yasumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):214-8. PubMed ID: 8515601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory determination of heparin cofactor II.
    Ezenagu LC; Brandt JT
    Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
    Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thrombosis patients with familial antithrombin-III deficiency treated with heparin and antithrombin].
    Brandt P
    Ugeskr Laeger; 1981; 143(34):2145-8. PubMed ID: 7281335
    [No Abstract]   [Full Text] [Related]  

  • 34. [The diagnosis of congenital antithrombin III deficiency and abnormality].
    Takahashi K; Yamagishi R; Sakuragawa N
    Rinsho Byori; 1987 May; 35(5):505-10. PubMed ID: 3302410
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of newly developed technology in blood coagulation disorders].
    Matsuo T
    Rinsho Byori; 2002 May; 50(5):506-12. PubMed ID: 12078050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.
    De Stefano V; Triolo L; De Martini D; Ferrelli R; Mori R; Leone G
    J Lab Clin Med; 1987 May; 109(5):550-5. PubMed ID: 3572202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.
    Aiach M; Roncato M; Chadeuf G; Dezellus P; Capron L; Fiessinger JN
    Thromb Haemost; 1988 Aug; 60(1):94-6. PubMed ID: 3187951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behaviour of antithrombin III abnormalities in the crossed immunoelectrophoresis system.
    Girolami A; Cappellato G; Vicarioto MA; Vergolani A; Traverso R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):159-64. PubMed ID: 2581861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombophilia in a patient with congenital deficiency of AT III].
    Miljić P; Colović M; Stanojević M; Elezović I; Bosković D
    Srp Arh Celok Lek; 1994; 122(11-12):344-6. PubMed ID: 17974415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.